In nearly four out of ten patients, non-small cell lung cancer (NSCLC) has already progressed to stage 4 by the time it is detected. This means the disease has spread beyond its original site to other areas of the body, including elsewhere in the affected lung. At that point, the condition may be considered inoperable. [...]